Quantitative fMRI-derived brain signals for clinical development

Our platform analyzes whole-brain directional information flow from resting-state fMRI to generate quantitative fMRI-derived brain signals to support exploratory patient stratification, enrichment, and research endpoints in CNS drug development.

We are engaging with research and industry partners to evaluate translational use cases and explore early pilot collaborations.